Sysmex Inostics, a Sysmex Corporation subsidiary, empowers discoveries in oncology by providing cost-effective and ultra-sensitive quantitative liquid biopsy solutions with groundbreaking digital PCR (OncoBEAM™) and NGS (Plasma-Safe-SeqS) technologies.
Developed by experts at Johns Hopkins University with the philosophy of “no molecule left behind,” these proprietary technologies have been optimized to ensure low-frequency mutant molecule (<0.05% MAF) detection with a high degree of specificity. Focused, flexible genomic coverage allows superior sensitivity and reduces costs.
As pioneers in blood-based cell-free tumor DNA (ctDNA) mutation detection, Sysmex Inostics has provided custom assays and CLIA-certified lab services to leading BioPharma companies over the last 10 years with the overall goal: to develop therapeutics that extend lives and provide diagnostics to monitor response to therapy, identify targetable resistance alterations, and detect minimal residual disease (MRD).
Sysmex Inostics’ Plasma-Safe-SeqS and OncoBEAM™ solutions are readily available and customizable to support your clinical trials and research needs. OncoBEAM™ tests are available through a CLIA-certified laboratory for routine clinical analysis and distributed products in the E.U.
Sysmex Inostics’ U.S. headquarters and CLIA-certified laboratory is based in Baltimore. The European headquarters for research and development are located in Hamburg, Germany.
The Sysmex Way
The Sysmex Way is a good representation of who we are, and how we want to act.
One of the core features of the Sysmex Way is trust. Clients must trust the fact that our solutions solve their challenges. And they must trust our products, services, and staff. Ideally, our employees trust in their abilities and that of the company.
We are good at what we do and have every justification to be confident. In almost all areas our employees are given a broad scope for decision-making. Experience teaches us that having confidence in our employees translates into close involvement with the company – a great, mutually-reinforcing circle.
We greatly appreciate competence and teamwork, and the remarkable diversity and creativity generated by simply letting people be who they really are.
Want to join the team?
When you join our team, you become part of our simple yet powerful mission: help defeat cancer.